Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't ...
Tag: Weight
FDA approves Eli Lilly weight loss pill
FDA approves Eli Lilly weight loss pill - CBS News
Airlines to save big money on fuel as new weight loss pills gain popularity, Wall Street says
Celsopupo | Istock | Getty ImagesWall Street is finding an unexpected beneficiary of America's weight loss boom: airlines.With the first ...
MCX shares rise 3% to hover near record high as Morgan Stanley upgrades stock to ‘equal weight’
Shares of Multi Commodity Exchange of India (MCX) traded strongly on Wednesday, hovering close to their all-time high, after global ...
Bitcoin Feels The Weight Of Quantum Risk Concerns, Industry Leaders Warn
Concerns over quantum computing are weighing on Bitcoin’s price and slowing some investment flows, amid a sharp divide between developers ...
For investors all-in on Magnificent 7-led market, ‘equal weight’ is trending as stock call for 2026
Investors are facing a period of historically high concentration in the S&P 500 Index headed into 2026, with a small ...
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug ...
CNBC Daily Open: The weight of Nvidia’s crown
Jensen Huang is interviewed by media during a reception for the 2025 Queen Elizabeth Prize for Engineering, at St James' ...
Where the blockbuster weight loss drug market stands today — and what’s coming next
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...
Too much weight on too few stocks? Gurmeet Chadha suggests broader metrics for index composition
As Indian equity markets continue to evolve, some believe it's time to revisit the methodology behind index composition, particularly in ...
